NCT01052558.

Trial name or title	GTS400 stent implantation in conjunction with cataract surgery in subjects with open‐angle glaucoma
Methods	Study design: parallel‐group RCT Unit of randomization: not reported Number randomized: not reported Unit of analysis: not reported Number analyzed: not reported Exclusions and losses to follow‐up: not reported Handling of missing data: not reported
Participants	Country: US Age: not reported Gender: not reported Inclusion criteria: diagnosed with OAG in the study eye using 1–3 glaucoma medications able and willing to attend follow‐up visits for 2 years postoperation able and willing to sign informed consent Exclusion criteria: PEXG and PG prior glaucoma surgery of any type Diagnoses in participants: OAG
Interventions	Intervention 1: cataract surgery with subsequent implantation of GTS400 stents Intervention 2: cataract surgery Length of follow‐up: 1 year
Outcomes	Primary outcomes: proportion of participants with 12‐month diurnal IOP ≤ 21 mmHg without use of ocular hypotensive medications for ≥ 4 weeks prior to 12‐month visit Secondary outcomes: not reported Safety outcomes: not reported
Starting date	20 January 2010
Contact information	No contact details
Notes	Type of study: awaiting classification – described as "completed" on ClinicalTrials.gov Funding source: Glaukos Corporation, Laguna Hills, CA, USA provided funding/support Disclosures of interest: not reported Publication language: not reported Trial registration: NCT01052558